Risk-based quality management (RBQM) is becoming central to clinical trial [...]

Alto Neuroscience has completed patient enrollment in its Phase 2 [...]

Hansa Biopharma has reported a 135% increase in fourth-quarter revenue [...]

Full results from the Phase 3 KALOS and LOGOS trials [...]

Evogene Ltd and Shanghai Lishan Biopharmaceuticals Co. have entered into [...]

AmacaThera has been named Emerging Company of the Year by [...]

Syngene International has entered a collaboration with Johns Hopkins University [...]

IgniteData has appointed Laura Hilty as chief strategy officer and [...]

BOOST Pharma has appointed Hans Schambye as its new chief [...]

Evinova and Bristol Myers Squibb have entered a strategic collaboration [...]